Zepbound's list price without insurance runs $1,000-$1,060/month. Here's exactly why, what Eli Lilly's savings programs actually offer, and how compounded tirzepatide delivers the same active medication for a fraction of the cost.
Zepbound (tirzepatide) without insurance costs approximately $1,000-$1,060 per month at list price. As with all brand-name GLP-1 medications, this number reflects manufacturing, device, and brand costs — and it's not the only path to access tirzepatide.
Why Zepbound costs what it costs
Zepbound is Eli Lilly's brand-name, FDA-approved tirzepatide formulation specifically for chronic weight management (Mounjaro is the same active molecule approved for type 2 diabetes). The pricing reflects the proprietary injector pen, manufacturing costs, and patent-protected exclusivity — tirzepatide has no generic version available.
~$1,000
Zepbound list price per month without insurance
2026 pricing
$349-499
Lilly Direct self-pay pricing (varies by dose)
Manufacturer program
$149-199
Compounded tirzepatide — same active molecule
Telehealth pricing
Your real options compared
| Option | Monthly cost | What you get |
|---|
| Zepbound at list price | ~$1,000-$1,060 | Brand pen, full self-pay price |
| Lilly Direct self-pay | $349-$499 | Brand Zepbound vials, lower doses cheaper, direct from manufacturer |
| Compounded tirzepatide | $149-199 | Same active molecule, licensed compounding pharmacy, physician-prescribed |
Lilly Direct — what it actually offers
Eli Lilly's direct-to-consumer self-pay program offers Zepbound vials (not the auto-injector pen) at significantly reduced cash prices for patients without insurance coverage — starting around $349/month for lower starting doses and increasing somewhat at higher maintenance doses. This is real, FDA-approved Zepbound at a meaningfully better price than standard list price, and worth checking directly if brand-name matters to you specifically.
Why most patients choose compounded tirzepatide instead
Compounded tirzepatide contains the same active molecule as both Zepbound and Mounjaro. A licensed compounding pharmacy prepares it from an individual physician prescription rather than Eli Lilly's branded manufacturing process.
At $149-199/month, compounded tirzepatide costs roughly 80-85% less than Zepbound's list price, and still meaningfully less than even the Lilly Direct self-pay rate — while delivering the same dual GLP-1/GIP receptor activation.
2026 regulatory note: The FDA has proposed restrictions on large-scale 503B compounding of tirzepatide and semaglutide. Availability varies by platform and is evolving — verify current availability directly with any provider you're considering. Smaller-scale 503A pharmacies serving individual patient prescriptions continue to operate under different rules.
How to access compounded tirzepatide
- Check eligibility — BMI 30+, or 27+ with a qualifying condition. Use our free eligibility checker.
- Complete an online intake reviewed by a licensed physician.
- Receive your prescription with an appropriate titration schedule, typically starting at 2.5mg.
- Medication ships from a licensed compounding pharmacy, properly labeled and dosed.
Skip the $1,000/month price tag
DirectMeds offers physician-supervised compounded tirzepatide from $149/month — the same active molecule as Zepbound and Mounjaro, without the brand markup. Free eligibility check.
Check eligibility at DirectMeds →
Frequently asked questions
How much does Zepbound cost without insurance?
Zepbound's list price without insurance is approximately $1,000-$1,060 per month. Eli Lilly's direct-to-consumer self-pay program (Lilly Direct) offers vials starting around $349/month for lower doses. Compounded tirzepatide through telehealth platforms costs $149-199/month and provides the same active molecule without requiring insurance.
Is compounded tirzepatide the same as Zepbound?
The active ingredient is identical — both are tirzepatide, activating the same GLP-1 and GIP receptors. Zepbound is Eli Lilly's FDA-approved brand-name auto-injector pen; compounded tirzepatide is prepared by a licensed compounding pharmacy from an individual physician prescription, typically in vial-and-syringe form, at significantly lower cost.
What is the cheapest way to get tirzepatide?
Compounded tirzepatide through licensed telehealth platforms is typically the most affordable legal option, at $149-199/month, compared to Zepbound's list price of approximately $1,000/month or Lilly Direct's self-pay pricing of $349-499/month. Eligibility, physician oversight, and proper labeling should always be verified regardless of which option you choose.